This product is indicated for the treatment of severe infections in adults caused by susceptible strains, including hospital-acquired pneumonia (late-onset hospital-acquired pneumonia; community-acquired pneumonia requiring ICU admission for critically ill patients); bronchiectasis with infection; intra-abdominal infections; bloodstream infections; skin and soft tissue infections; bone and joint infections; reproductive system infections; urinary system infections. It can also be used for acute exacerbations of moderate to severe chronic obstructive pulmonary disease with a risk of Pseudomonas aeruginosa infection.